Unibest
← Back to patent-cliff list

CAS 172152-35-1

2-[[(4-Methoxy-3-methylpyridin-2-yl)methyl]sulfanyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)-5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole

Codes: Sodium ilaprazole-009, ILAP-007

Application context (from source-drug indications)

Peptic ulcerSodium ilaprazolePeptic ulcer bleedingSodium ilaprazoleDuodenal ulcerSodium ilaprazoleGastric ulcerSodium ilaprazolePeptic oesophagitisSodium ilaprazoleDuodenal ulcerIlaprazoleGastro-oesophageal reflux diseaseIlaprazolePeptic ulcer bleedingIlaprazoleOesophagitisIlaprazole

Source drugs (routes using this intermediate)

DrugTierExpiry
Sodium ilaprazoleTier C — Watch / trade-
IlaprazoleTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Sodium ilaprazoleOptimised routesteps: 2total yield: /
IlaprazoleOptimised routesteps: 5total yield: 124.3 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.